We selected five breast cancer–relevant genes, namely, ALDH1A, BRCA, TP53, BCL2, and CD44, for validation, using SYBR Green real-time PCR assays in n = 10 IDC samples. This evidence concerns the gene CD44 and breast carcinoma.